Top3 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Top3 protein, a key enzyme involved in DNA processing and other cellular functions. These inhibitors function by binding to the active site of the Top3 protein, where they block its interaction with DNA or other necessary substrates. By occupying the active site, Top3 inhibitors prevent the enzyme from catalyzing its usual reactions, thereby halting its biological function. In some cases, these inhibitors may also bind to allosteric sites, which are regions of the protein separate from the active site. Binding to allosteric sites induces conformational changes in the protein's structure, which can diminish or completely inhibit its activity. The interaction between Top3 inhibitors and the protein is typically driven by non-covalent forces, such as hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic interactions, which help to stabilize the inhibitor-protein complex.
The structural diversity of Top3 inhibitors is key to their function, with their molecular frameworks tailored to interact with the specific regions of the Top3 protein. These inhibitors often incorporate functional groups such as hydroxyl, amine, or carboxyl groups, which allow them to form hydrogen bonds with residues in the active site of the protein. Additionally, the presence of aromatic rings and heterocyclic structures within Top3 inhibitors enhances hydrophobic interactions with non-polar areas of the protein, thereby increasing their binding affinity and stability. The physicochemical properties of these inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure that they can bind effectively to the Top3 protein and remain stable in different biological environments. This balance between hydrophilic and hydrophobic properties allows Top3 inhibitors to achieve strong, specific interactions with the protein, ensuring their ability to modulate the protein's activity under various conditions.
Items 11 to 20 of 21 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Teniposide | 29767-20-2 | sc-204910 sc-204910A | 25 mg 100 mg | $73.00 $235.00 | 6 | |
Teniposide inhibits Top3 by forming a ternary complex with the enzyme and DNA, preventing the resealing of DNA breaks. This traps Top3 on DNA, leading to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $112.00 $273.00 $1564.00 $5205.00 | 9 | |
RITA inhibits Top3 by binding to its active site, blocking the enzyme's catalytic activity. This prevents Top3 from resolving DNA topological structures, leading to inhibition of Top3 activity. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
Selectively inhibits mutant forms of EGFR in cells, disrupting signaling and tumor growth. | ||||||
NSC 319726 | 71555-25-4 | sc-477736 | 10 mg | $159.00 | ||
NSC 319726 inhibits Top3 by disrupting the enzyme-DNA interaction, preventing Top3 from resolving DNA topological structures. This leads to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||
β-Lapachone | 4707-32-8 | sc-200875 sc-200875A | 5 mg 25 mg | $112.00 $459.00 | 8 | |
Beta-Lapachone inhibits Top3 by generating reactive oxygen species (ROS) that induce DNA damage and prevent Top3-mediated DNA re-ligation. This leads to the accumulation of DNA breaks and inhibition of Top3 activity. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Inhibits Janus kinases (JAK1 and JAK2), reducing inflammation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits Top3 by disrupting the enzyme-DNA interaction, preventing Top3 from resolving DNA topological structures. This leads to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
Ciprofloxacin inhibits Top3 by binding to the enzyme's active site and blocking its catalytic activity. This prevents Top3 from resolving DNA topological structures, leading to inhibition of Top3 activity. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
Binds to BCL-2 proteins, promoting apoptosis in cells by disrupting the anti-apoptotic function of BCL-2. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine inhibits Top3 by intercalating into DNA and stabilizing the enzyme-DNA complex, preventing the re-ligation of DNA breaks. This traps Top3 on DNA, leading to the accumulation of DNA damage and inhibition of Top3 activity. | ||||||